CDC Webinar on March 9: What Every Clinician Should Know about COVID-19 Vaccine Safety and Effectiveness, and Learn How to Address Patient Questions and Concerns

March 9, 2-3PM EDT

No Registration Required

A few minutes before the webinar starts, please click on the Zoom link to join.

Passcode: 528346

Or Telephone: Dial(for higher quality, dial a number based on your current location): US:

  • +1 669 254 5252 or
  • +1 646 828 7666 or
  • +1 551 285 1373 or
  • +1 669 216 1590

Or iPhone one-tap:

  • US: 16692545252,,1600016316#,,,,*528346# 
  • +16468287666,,1600016316#,,,,*528346# 

Webinar ID: 160 001 6316

COVID-19 vaccines are safe and effective.

More than 50 million people in the United States have received COVID-19 vaccines, and these vaccines have undergone the most intensive safety monitoring in U.S. history. This monitoring includes using both established and new safety monitoring systems to make sure that COVID-19 vaccines are safe.

During this COCA call, clinicians will receive an update on COVID-19 vaccine safety and effectiveness for the Pfizer-BioNTech and Moderna vaccines, including data on COVID-19 vaccine safety in pregnancy. Clinicians will also get information about the v-safe COVID-19 Pregnancy Registry, which collects additional health information that helps CDC monitor the safety of COVID-19 vaccines in people who are pregnant.

As more people in the U.S. become eligible to receive COVID-19 vaccines, clinicians are likely to hear increasing questions and concerns from patients who want more information about the safety and effectiveness of COVID-19 vaccines. It is natural for people to have these questions, and clinicians play a critical role in answering them. In this call, clinicians will learn effective strategies for responding to safety and efficacy questions they may hear, and in doing so, promote confidence, communication, and update of COVID-19 vaccines.

Learning Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.


  • Tom Shimabukuro, MD, MPH, MBA
    • Vaccine Safety Team Lead
    • COVID-19 Response
    • Centers for Disease Control and Prevention
  • Kathleen Dooling, MD, MPH
    • Medical Officer
    • Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
    • COVID-19 Response
    • Centers for Disease Control and Prevention
  • Stephen Perez, RN, PhD
    • LT, U.S Public Health Service
    • Clinical Lead, Vaccine Confidence Team
    • COVID-19 Response Centers for Disease Control and Prevention

For More Information

  • If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.
  • The slide set will be available on the day of the call under “Call Materials” on the COCA Call webpage